Bausch Health
BHC
#3484
Rank
NZ$5.39 B
Marketcap
$14.59
Share price
-2.23%
Change (1 day)
29.05%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Operating Margin for Bausch Health (BHC)

Operating Margin as of November 2024 (TTM): -4.45%

According to Bausch Health 's latest financial reports and stock price the company's current Operating Margin is -4.45%. At the end of 2023 the company had an Operating Margin of -4.45%.

Operating Margin history for Bausch Health from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-4.45%180.47%
2022-1.59%-86.92%
2021-12.14%4.35%
2020-11.64%-45.52%
2019-21.36%-56.91%
2018-49.57%148.39%
2017-19.96%-20.72%
2016-25.17%1596.5%
2015-1.48%-111.55%
201412.84%-156.38%
2013-22.78%101.14%
2012-11.33%1427.44%
2011-0.74%-96.29%
2010-20.00%-193.79%
200921.32%27.24%
200816.76%-32.33%
200724.77%14.99%
200621.54%-27.71%
200529.79%49.54%
200419.92%-470.09%
2003-5.38%-138.82%
200213.87%-21.26%
200117.61%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-8,391.15% 188,465.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-34.14% 667.19%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.